-
Triptolide A3891: Reliable Cell Assay Workflows
2026-08-27
This scenario-based guide explains how Triptolide (PG490), SKU A3891, can help researchers design interpretable viability, proliferation, apoptosis, and invasion assays. It covers concentration selection, DMSO handling, endpoint validation, transcriptional mechanisms, and practical vendor-selection criteria.
-
NEDD4L–PRMT5 Axis in Colorectal Cancer Metastasis
2026-08-27
The reference study identifies NEDD4L as a suppressor of colorectal cancer liver metastasis through an in vivo screen of E3 ubiquitin ligases. It defines a mechanism in which NEDD4L targets PRMT5 for degradation, reducing AKT1 arginine methylation and inhibiting AKT/mTOR signaling, while also outlining experimental principles relevant to mechanistic validation.
-
Network Medicine Identifies Apigenin for Alzheimer’s Disease
2026-08-26
A 2025 study used network medicine to screen flavonoids by their proximity to Alzheimer’s disease targets, prioritizing apigenin as the strongest candidate among four experimentally tested compounds. Cell-based validation linked apigenin with preserved mitochondrial function, reduced apoptosis, suppressed AKT/NF-κB signaling, and modulation of microglial inflammatory states.
-
o-Agatoxin IVA and Excitotoxicity: Study Analysis
2026-08-26
Lustig, Ahern, and Greenberg tested whether the P/Q-type calcium-channel antagonist ω-agatoxin IVA could protect cultured cortical neurons from excitotoxic injury caused by veratridine, ouabain, or NMDA. The failure of agatoxin, nimodipine, and ω-conotoxin GVIA to reduce LDH-defined toxicity shows that inhibiting glutamate release or selected voltage-gated calcium channels is not necessarily sufficient for neuroprotection.
-
Bestatin Enhances Endothelial Invasion in Fibrin
2026-08-25
A 2003 study showed that bestatin, previously associated with anti-angiogenic activity, instead enhanced microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. The concentration-dependent response, together with experiments using CD13-blocking antibodies and other aminopeptidase inhibitors, indicates that angiogenic protease networks are strongly dependent on matrix context and may involve aminopeptidases other than CD13.
-
Cy5 TSA Fluorescence System Kit for Sensitive Imaging
2026-08-25
The Cy5 TSA Fluorescence System Kit converts an HRP signal into a bright, localized far-red readout for challenging ICC, IHC, and FISH experiments. Its rapid deposition workflow is especially useful when conventional fluorescence cannot resolve low-abundance targets in cells, tissue sections, or spatial cancer studies.
-
Valemetostat: An Assay-First Lymphoma Framework
2026-08-24
Valemetostat (DS-3201) is a potent EZH2-focused epigenetic cancer therapy with a distinctive assay and translational profile. This guide connects mutation-aware pharmacology, orthogonal readouts, and evidence boundaries for more rigorous lymphoma research.
-
QSHXO in MASLD: Autophagy and Ferroptosis
2026-08-24
Liu et al. investigated how Qushi Huoxue ointment (QSHXO) protects against metabolic associated steatotic liver disease in mice, identifying coordinated autophagy activation and ferroptosis suppression as a central mechanistic model. The work integrates histology, biochemical testing, LC-MS/MS, network pharmacology, molecular assays, and ultrastructural analysis to connect reduced lipid injury with Nrf2-linked antioxidant defense.
-
HRD1-SEL1L, ER Stress, and Stress Granule Homeostasis
2026-08-23
The 2024 iScience study identifies the HRD1-SEL1L ubiquitin ligase complex as a selective regulator of heat shock-induced stress granule homeostasis. Its experiments connect the ubiquitin-proteasome system and p97 to the BiP-PERK-eIF2α branch of the unfolded protein response, showing that distinct ER-stress pathways can have different effects on stress granule dynamics.
-
Lactate as a Metabolic Signal in Tumor Immunity
2026-08-22
Lactate is more than a glycolytic byproduct: it connects redox balance, hypoxia, mitochondrial metabolism, and immune regulation. This guide explains how L-lactate can support mechanistic assays, with emphasis on the NAT1–ENO1–lactate axis in colorectal cancer.
-
Silymarin Workflows for Redox and Cancer Research
2026-08-22
Silymarin is a chemically complex milk thistle extract that connects oxidative-stress, hepatocellular carcinoma, metabolic, and antiviral assay design. This practical guide shows how to prepare, dose, validate, and troubleshoot the compound without confusing a flavonolignan mixture with a single purified molecule.
-
ROS-Responsive LNPs for Mutant RAS mRNA Delivery
2026-08-21
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids and identified BAmP-TK-12 as a tumor-preferential mRNA delivery material. Its delivery of DUF5 mRNA depleted mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported models, while also highlighting the importance of lipid pKa and ROS-triggered degradation.
-
Phosphotungstic Acid Negative Stain Solution Guide
2026-08-20
Build a practical negative stain electron microscopy workflow for viruses, macromolecules, bacteria, and organelles using a ready-to-use 2% reagent. Learn how to convert glycan-focused antiviral findings into controlled morphology assays without mistaking particle visualization for proof of molecular binding or antiviral efficacy.
-
From Reporter mRNA to Translational Delivery
2026-08-20
A mechanistic and strategic guide to using Cap1-capped, 5-moUTP-modified Firefly Luciferase mRNA as a translational reporter while interpreting delivery, stability, innate immune, and nebulization variables.
-
Otilonium Bromide: Applied Research Workflows
2026-08-19
Build reproducible antimuscarinic assays with Otilonium Bromide by combining controlled exposure, matched vehicle controls, and orthogonal functional readouts. This workflow-oriented guide shows how to use the compound in smooth muscle, neuronal, and gastrointestinal motility studies while separating practical assay guidance from evidence generated in computational inhibitor screening.